Biocept to Present at the LD Micro Main Event XV

Rhea-AI Summary

Biocept, Inc. (Nasdaq: BIOC) will present at the LD Micro Main Event XV on October 26 at 2:30 p.m. PT. The event will be held at the Luxe Sunset Boulevard Hotel in Los Angeles. A live webcast of the presentation will be available on the company's website, where it will also be archived for later viewing. Biocept specializes in molecular diagnostics for cancer treatment, focusing on CNS metastases with its proprietary CNSide™ assay. The company also provides nationwide COVID-19 RT-PCR testing efforts.

SAN DIEGO--(BUSINESS WIRE)-- Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that management will present at the LD Micro Main Event XV on Wednesday, October 26 at 2:30 p.m. Pacific time (5:30 p.m. Eastern time). The conference is being held at the Luxe Sunset Boulevard Hotel in Los Angeles.

A webcast of the presentation will be live and archived on the Events and Presentation section of the company website.

About Biocept

Biocept, Inc. develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. Biocept focuses on cancers that have metastasized into the central nervous system and has developed its proprietary CNSide™ cerebrospinal fluid assay that detects metastatic cancer and quantitatively analyzes cerebrospinal fluid tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. Biocept also is leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic. For more information, visit www.biocept.com. Follow Biocept on Facebook, LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221019005017/en/

Investor and Media Contact

LHA Investor Relations

Jody Cain

Jcain@lhai.com, (310) 691-7100

Source: Biocept, Inc.

FAQ

When will Biocept present at the LD Micro Main Event XV?

Biocept will present on October 26 at 2:30 p.m. Pacific time.

Where is the LD Micro Main Event XV being held?

The event is held at the Luxe Sunset Boulevard Hotel in Los Angeles.

How can I watch the Biocept presentation?

You can watch the live webcast on Biocept's website, where it will also be archived.

What is Biocept's focus in molecular diagnostics?

Biocept focuses on providing diagnostic assays for cancer, particularly in cases of CNS metastases.

What is the significance of the CNSide™ assay?

The CNSide™ assay detects metastatic cancer and analyzes cerebrospinal fluid tumor cells for molecular markers.